Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia

We identified a subset of genes involved in chromatin remodeling whose mRNA expression changes in differentiating mouse erythroleukemia (MEL) cells. We furthermore tested their mRNA expression patterns in normal and malignant CD34+ bone marrow cells. SMARCA5, imitation switch gene homologue, was rapidly silenced during in vitro erythroid differentiation of MEL cells whereas it was up-regulated in CD34+ hematopoietic progenitors of acute myeloid leukemia (AML) patients. Moreover, SMARCA5 mRNA levels decreased in AML CD34+ progenitors after the patients achieved complete hematologic remission. We detected high levels of SMARCA5 mRNA in murine bone marrow and spleen and monitored its expression in these hematopoietic tissues during accelerated hematopoiesis following hemolytic anemia induced by phenylhydrazine. SMARCA5 expression levels decreased after the onset of accelerated erythropoiesis. Our data suggest that both in vitro and in vivo induction of differentiation is followed by down-regulation of SMARCA5 expression. In CD34+ AML progenitors over-expression of SMARCA5 may thus dysregulate the genetic program required for normal differentiation.

[1]  J. Mackay,et al.  Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers , 1999, The EMBO journal.

[2]  M. Bustin,et al.  Differentiation-dependent alteration in the chromatin structure of chromosomal protein HMG-17 gene during erythropoiesis. , 1991, Journal of molecular biology.

[3]  G. Längst,et al.  ISWI is an ATP-dependent nucleosome remodeling factor. , 1999, Molecular cell.

[4]  G. Längst,et al.  High Mobility Group 1 Protein Is Not Stably Associated with the Chromosomes of Somatic Cells , 1997, The Journal of cell biology.

[5]  J. Diffley,et al.  DNA binding properties of an HMG1-related protein from yeast mitochondria. , 1992, The Journal of biological chemistry.

[6]  M. Bustin,et al.  Developmental changes in the expression of high mobility group chromosomal proteins. , 1991, The Journal of biological chemistry.

[7]  Johnson M Liu,et al.  Chromatin remodeling and leukemia: new therapeutic paradigms. , 1999, Blood.

[8]  P. Becker,et al.  Chromatin-remodeling factors: machines that regulate? , 1998, Current opinion in cell biology.

[9]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[10]  N. Rekhtman,et al.  Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. , 1999, Genes & development.

[11]  M. Bustin,et al.  Clusters of nucleosomes containing chromosomal protein HMG-17 in chromatin. , 1997, Journal of molecular biology.

[12]  R. Kingston,et al.  ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. , 1999, Genes & development.

[13]  H. Lodish,et al.  Constantinescu, S.N. et al. The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid. Blood 91, 1163−1172 , 1998 .

[14]  Y. Nakamura,et al.  Cloning and mapping of SMARCA5 encoding hSNF2H, a novel human homologue of Drosophila ISWI , 1998, Cytogenetic and Genome Research.

[15]  G. Bellomo,et al.  The HMG protein T160 colocalizes with DNA replication foci and is down-regulated during cell differentiation. , 1999, Experimental cell research.

[16]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Greaves,et al.  Loops, Lineage, and Leukemia , 1998, Cell.

[18]  H. Lodish,et al.  Structure, function, and activation of the erythropoietin receptor. , 1993, Blood.

[19]  H. Lodish,et al.  The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid. , 1998, Blood.

[20]  P. Marks,et al.  Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. , 1977, Cancer research.

[21]  J. Dick,et al.  Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. , 1995, Human molecular genetics.

[22]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[23]  Matthias Mann,et al.  Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II , 1997, Nature.